Fast track call on COVID-19 launched
On 3 March 2020, ihe Innovative Medicines Initiative (IMI), a public-private partnership between the European Commission and the pharmaceutical industry, has launched a fast-track call for research proposals to develop treatments and diagnostics in response to the COVID-19 outbreak. Up to €45 million of the funding will come from Horizon 2020 and a commitment of a similar scale is expected from the pharmaceutical industry so that the total investment could reach up to €90 million
The IMI call invites proposals for projects to develop treatments and diagnostics to better tackle the COVID-19 outbreak and to increase preparedness for potential future outbreaks.This call is part of the coordinated EU response to the public health threat of COVID-19, hand in hand with the emergency research funding mobilised recently under Horizon 2020. The special call for expression of interest (SC1-PHE-CORONAVIRUS-2020) was launched on January 30 with a budget of €10 million. In the coming weeks, the selected projects will start their work to advance the knowledge on COVID-19 and its impact on infected people, with the aim of contributing to an efficient patient management and/or public health preparedness and response.
For more information: